Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Net cash used in operating activities:	$ (76,524)	$ (126,512)
Cash flows from investing activities
Investment in patents	(1,687)	(5,267)
Net cash used in investing activities	(1,687)	(5,267)
Cash flows from financing activities
Payments on convertible notes	(195,000)
Proceeds from private placement offering		50,625
Net cash provided by financing activities	(195,000)	50,625
Net change in cash	(273,211)	(81,154)
Cash and cash equivalents at beginning of period	1,980,015	134,125
Cash and cash equivalents at end of period	1,706,804	52,971
Supplemental Cash Flow Information
Cash paid for interest	3,819
Cash paid for income taxes
Non-Cash Transactions
Stock issued for accrued liabilities	$ 496,736